IBRN vs SCHD5YIBRNIBRNAvsBSCHDSCHDiShares Neuroscience and Healthcare ETF · $9MSchwab U.S. Dividend Equity ETF · $123BReturns · dividends in+18.7%3 years · per year$16,710 · $17,257+19.9%[…]5 years · per year[…] · $16,429+10.4%Cost and income0.47%Expense ratio$47 · $6 on $10k · lower wins0.06%0.93%12-mo yield$93 · $293 on $10k
Overlap: IBRN, SCHD, VGTToday2.2%most shared, SCHD and VGTIBRNSCHDVGTIBRN—0.0%0.0%SCHD0.0%—2.2%VGT0.0%2.2%—End-of-day Nov 12, 2026 · share held in common · outlined: the pair in versus
IBRN vs SCHD5YAIBRNiShares Neuroscience and Healthcare[…]vsSCHDBSchwab U.S. Dividend Equity$16,429MeasureIBRNSCHDFee0.47%0.06%Cost on $10k a year$47$6Yield0.93%2.93%5 years, per year[…]+10.4%3 years, per year+18.7%+19.9%Worst drop · 1Y−26.3%−6.9%Volatility · 1Y27.0%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1VGTVanguard Information Technology ETFReadDesk0.09%0.42%−0.6%+20.4%+17.5%+28.3%+15.9%−17.5%$154.5B2BSCHDSchwab U.S. Dividend Equity ETFReadDesk0.06%2.93%−0.2%+34.2%+36.8%+19.9%+10.4%−6.9%$122.7B3AIBRNiShares Neuroscience and Healthcare ETFReadDesk0.47%0.93%−3.0%+6.3%+19.3%+18.7%new−26.3%$9MEnd-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1VGTVanguard Information Technology ETFReadDesk0.09%0.42%−0.6%+20.4%+17.5%+28.3%+15.9%−17.5%$154.5B2BSCHDSchwab U.S. Dividend Equity ETFReadDesk0.06%2.93%−0.2%+34.2%+36.8%+19.9%+10.4%−6.9%$122.7B3AIBRNiShares Neuroscience and Healthcare ETFReadDesk0.47%0.93%−3.0%+6.3%+19.3%+18.7%new−26.3%$9MEnd-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
SCHD vs VIGYTDSchwabSCHDSA+34.2%vsBVVIGVanguard+16.0%Jan 1Nov 12+34.2%+16.0%+34.2%Year to date+16.0%2.9%Yield1.4%$123BAssets$109B2–0SCHD winsEnd-of-day Nov 12, 2026
XLK vs VGTYTDSPDRXLKSA+21.1%vsBVVGTVanguard+20.4%Jan 1Nov 12+21.1%+20.4%+21.1%Year to date+20.4%0.08% · $8Fee · on $10k a year0.09% · $9$113BAssets$155B2–0XLK winsEnd-of-day Nov 12, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+7.8%vsBJMJEPIJ.P. Morgan+8.3%Jan 1Nov 12+7.8%+8.3%+7.8%Year to date+8.3%12.2%Yield7.9%$41.8BAssets$46.8B1–1levelEnd-of-day Nov 12, 2026
Overlap: IBRN, SCHD, VGTToday2.2%most shared, SCHD and VGTIBRNSCHDVGTIBRN—0.0%0.0%SCHD0.0%—2.2%VGT0.0%2.2%—End-of-day Nov 12, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$287most kept, SCHDSCHD$293 − $6 = $287IBRN$93 − $47 = $46VGT$42 − $9 = $33KeptFeeEnd-of-day Nov 12, 2026 · yield in dollars minus the fee